Arcutis Biotherapeutics Clinical Site 232

Winnepeg, Manitoba R3M 3Z4

0 studies enrolling now · 2 studies all time

What they study most

Chronic Plaque Psoriasis

Studies at this site

• Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis — Completed
• Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis — Completed